A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)

NCT04447755 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

127

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed or Refractory Solid Tumors

Interventions

DRUG: Lenvatinib

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]